Factors Affecting Adherence With Follow-up Appointments in HIV Patients
- PMID: 36299938
- PMCID: PMC9586838
- DOI: 10.7759/cureus.29424
Factors Affecting Adherence With Follow-up Appointments in HIV Patients
Abstract
Currently, the majority of new human immunodeficiency virus (HIV) infections are transmitted by individuals with untreated HIV. In this retrospective study, we examined associations between demographic factors, viral suppression, acquired immunodeficiency syndrome (AIDS) status (CD4 count <200), and adherence to clinical follow-up in individuals living with HIV. Of the 489 patients, 135 (27.6%) were females, 235 (48.1%) were over 50 years old, 191 (39.1%) had Medicaid, Medicare, or Ryan White Insurance, 25 (5.1%) had CD4 counts below 200, and 207 (42.3%) were adherent to their clinic appointments. In univariable logistic regression analysis, age and viral load detectability were significantly associated with patient adherence to their clinic appointment. In multivariable analysis, only age remained significantly associated with clinic appointment adherence (Odds Ratio=2.1; 95% Confidence Interval=1.4, 3.1; P<0.001). Patients 50 years old or younger were half as likely to be adherent to their clinic appointments than patients over 50 years old. Gender and insurance status were not associated with viral suppression or AIDS status. The results illustrate the need for increased age-specific outreach to improve clinical adherence in younger individuals.
Keywords: adherence to therapy; follow-up appointment; hiv care; hiv viral load; uncontrolled hiv.
Copyright © 2022, O'Connell et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Ending the HIV epidemic in the U.S. [ Mar; 2022 ]. 2022. https://www.cdc.gov/endhiv/index.html https://www.cdc.gov/endhiv/index.html
-
- Understanding determinants of racial and ethnic disparities in viral load suppression. Feller DJ, Agins BD. J Int Assoc Provid AIDS Care. 2017;16:23–29. - PubMed
-
- Single-tablet regimens in HIV: does it really make a difference? Aldir I, Horta A, Serrado M. Curr Med Res Opin. 2014;30:89–97. - PubMed
-
- HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Spinner CD, Boesecke C, Zink A, Jessen H, Stellbrink HJ, Rockstroh JK, Esser S. Infection. 2016;44:151–158. - PubMed
-
- U=U taking off in 2017. The Lancet H. Lancet HIV. 2017;4:475.
LinkOut - more resources
Full Text Sources
Research Materials